Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Harvoni in treatment-experienced chronic HCV genotype 1
NCT01768286Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Jan 2013
- Primary completion
- Nov 2013
- Countries
- 1
01
Overview
A Phase 3 trial of ledipasvir in chronic hepatitis C virus infection (CHC), sponsored by Gilead Sciences. Started Jan 2013; status: completed.
02
Drugs
ledipasvir
03
Conditions
chronic hepatitis C virus infection (CHC)
Beyond the preview
Go deeper on NCT01768286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01768286.